Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies

Study Overview
=================
Brief Summary
-----------------
The purpose of this clinical study is to collect safety and performance data to support a demonstration of substantial equivalence of the Catheter Robotics Remote Catheter System to predicate devices when used to perform EP mapping of the right heart (atrium and ventricle).

Official Title
-----------------
Clinical Study to Evaluate the Effectiveness and Safety of the Catheter Robotics Amigo Remote Catheter System for Performing Right-Sided Electrophysiology Mapping Studies

Conditions
-----------------
Atrial Flutter, Ventricular Tachycardia

Intervention / Treatment
-----------------
* Device: Amigo catheter robot


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: > 18years of age. Indicated for a right-sided electrophysiology ablation study (e.g., atrial flutter, AVNRT, right-sided accessory pathway, or ventricular tachycardia). Willingness, ability, and commitment to participate in the procedure visit and a follow-up evaluation including a clinic visit at 7 (-0, +7) days after the study procedure. Completion of Informed Consent. Exclusion Criteria: Any contraindication to cardiac catheterization, including pregnancy. Enrollment in any other ongoing cardiac device trial. Right-sided cardiac prosthetics including implanted active energy devices with permanent leads in or through the right atrium and/or ventricle. Corrected or uncorrected atrial septal defect (ASD). Poor general health that, in the opinion of the Investigator, will not allow the subject to be a good study candidate (i.e., other disease processes, mental capacity, etc.). Medical condition that will require anticoagulation during study or ablation procedure. Presence of atrial fibrillation or atrial flutter at time of study procedure. Other condition observed prior to the procedure where, in the view of the physician, participation in the study could further present a risk to the subject. -

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Catheter Robot<br>device | Device: Amigo catheter robot<br>* The Amigo Catheter System is intended to facilitate manipulation, positioning and control of a Diagnostic Catheter.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Navigation Performance | Effectiveness Navigation Performance -- The ability to navigate the mapping catheter under Amigo control to at least 80% of 8 pre-specified anatomical locations over all subjects. | During Procedure | 
| Evaluation of Major Complications | Safety Evaluation of Major Complications definitely or probably related to Amigo-Controlled Mapping through Visit 3 follow-up. | Seven Days (visit 3), except for any subject with an ongoing SAE that is related to the study will be scheduled for additional evaluations at 14 day intervals. | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
atrial flutter, AVNRT, right sided accessory pathway, ventricular tachycardia, Patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.